✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Dishman Carbogen Amcis Ltd.

DCAL

Market Cap
₹3,376 Cr.
P/E
0.00

Dishman Carbogen Amcis Ltd.

About
Dishman Carbogen Amcis Limited (DCAL) is a fully integrated CRAMS player in the pharmaceutical industry, providing end-to-end, integrated, high-value CRAMS offering from process research & development… Read more
Dishman Carbogen Amcis Limited (DCAL) is a fully integrated CRAMS player in the pharmaceutical… Read more
Low
133
52W Range
High
308
  • Dishman Carbogen Amc
  • Sun Pharma Adv. Res
  • Zenotech Laboratorie
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

6 Yes

Positive for this company

1 Neutral

Neutral for this company

10 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Segment Break-Up - Marketable Molecules

Location Wise Break-Up - Contract Research & Contract Manufacturing (CRAMS)

Location Wise Break-Up

Therapeutic Area Break-Up

Operating Profit Break-Up

Operational Metrics

    locked
    Select a Metric
    • US DMF Filings (.)
    • Total reactor capacity (kL)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    FAQs on Dishman Carbogen Amcis Ltd. Business

    Dishman Carbogen Amcis Limited is a fully integrated CRAMS player with global presence offering end-to-end services in process research, development, and manufacturing of Active Pharmaceutical Ingredients.

    Dishman Carbogen Amc major competitors are Sun Pharma Adv. Res, Zenotech Laboratorie, Vivo Bio Tech, Jeevan Scientific, Syngene Internation., Suven Life Sciences, Hikal.
    Market Cap of Dishman Carbogen Amc is ₹3,275 Crs.
    While the median market cap of its peers are ₹2,855 Crs.

    Dishman Carbogen Amc seems to be less financially stable compared to its competitors.
    Altman Z score of Dishman Carbogen Amc is 1.48 and is ranked 8 out of its 8 competitors.

    View FAQ's On Shareprice
    Company Filing
    Discussions & Analysis
    Dishman Carbogen Amcis Ltd.
    View the discussion on ValuePickr
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material